Vitamin K2 supplier NattoPharma ASA has named Rudi De Man its new VP sales & business development, responsible for Europe and Asia.
“NattoPharma ASA recognizes that the European and Asian markets pose a huge growth potential for our science-based MenaQ7 Vitamin K2 as MK-7,” said Frode Bohan, chairman of the board of NattoPharma ASA, Norway. “This opportunity requires a dedicated hand, which is why we have added Rudi De Man to our global management team. He brings a deep understanding of these markets from his nutraceutical and food ingredients background, reinforcing NattoPharma’s great expectations for the future.”
Prior to joining NattoPharma, De Man held sales leadership and business development roles with FMC Health and Nutrition. His most recent position was Sales Director Europe, Middle East, Africa, and Eastern Europe for Food Stabilizers and Colors, where he was responsible for managing the Food and Personal Care business.
“With an extensive knowledge of the nutraceutical and pharmaceutical industries, we are confident De Man will be an engaging member of our global management team, guiding our current and potential partners on a mutually profitable path to create innovative products that take full advantage of our clinically validated MenaQ7 Vitamin K2 as MK-7,” said Hogne Vik, NattoPharma CEO.